Company profile for Omnivium Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Omnivium Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of difficult-to-make products. It focuses on developing difficult generic and 505(b)(2) products. Through our strong domestic and global partnerships, products will include both patented and off-patented brands and generics.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2131 Felver Court, Suite A, Rahway, New Jersey 07065
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

BePharma

Not Confirmed

envelop Contact Supplier

BePharma

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219048

FDA
23 Jan 2026

Drugs in Development

read-more
read-more

Details:

Numbrino (Cocaine HCl) is a small molecule drug candidate, which is currently being evaluated in Phase III clinical studies for the treatment of Anesthesia, Local.


Lead Product(s): Cocaine Hydrochloride

Therapeutic Area: Neurology Brand Name: Numbrino

Study Phase: Phase IIIProduct Type: Controlled Substance

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 17, 2025

blank

01

BePharma
Not Confirmed
BePharma
Not Confirmed

Details : Numbrino (Cocaine HCl) is a small molecule drug candidate, which is currently being evaluated in Phase III clinical studies for the treatment of Anesthesia, Local.

Product Name : Numbrino

Product Type : Controlled Substance

Upfront Cash : Inapplicable

December 17, 2025

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

Brand Name : CLEMASTINE FUMARATE

BePharma
Not Confirmed
arrow

Brand Name : CLEMASTINE FUMARATE

arrow
BePharma
Not Confirmed

Omnivium Pharmaceuticals

Dosage Form : TABLET;ORAL

Brand Name : CLEMASTINE FUMARATE

Dosage Strength : 2.68MG

Packaging :

Approval Date : 1993-10-31

Application Number : 73459

Regulatory Info : DISCN

Registration Country : USA

blank

02

Brand Name : NUMBRINO

BePharma
Not Confirmed
arrow

Brand Name : NUMBRINO

arrow
BePharma
Not Confirmed

Omnivium Pharmaceuticals

Dosage Form : SOLUTION;NASAL

Brand Name : NUMBRINO

Dosage Strength : 4%

Packaging :

Approval Date : 2020-01-10

Application Number : 209575

Regulatory Info : RX

Registration Country : USA

blank

03

Brand Name : GLYCOPYRROLATE

BePharma
Not Confirmed
arrow

Brand Name : GLYCOPYRROLATE

arrow
BePharma
Not Confirmed

Omnivium Pharmaceuticals

Dosage Form : INJECTABLE;INJECTION

Brand Name : GLYCOPYRROLATE

Dosage Strength : 0.2MG/ML

Packaging :

Approval Date : 2022-11-29

Application Number : 212871

Regulatory Info : RX

Registration Country : USA

blank

04

Brand Name : ISONIAZID

BePharma
Not Confirmed
arrow

Brand Name : ISONIAZID

arrow
BePharma
Not Confirmed

Omnivium Pharmaceuticals

Dosage Form : TABLET;ORAL

Brand Name : ISONIAZID

Dosage Strength : 100MG

Packaging :

Approval Date : 1997-06-26

Application Number : 40090

Regulatory Info : RX

Registration Country : USA

blank

05

Brand Name : ISONIAZID

BePharma
Not Confirmed
arrow

Brand Name : ISONIAZID

arrow
BePharma
Not Confirmed

Omnivium Pharmaceuticals

Dosage Form : TABLET;ORAL

Brand Name : ISONIAZID

Dosage Strength : 300MG

Packaging :

Approval Date : 1997-06-26

Application Number : 40090

Regulatory Info : RX

Registration Country : USA

blank

06

Brand Name : MONOKET

BePharma
Not Confirmed
arrow

Brand Name : MONOKET

arrow
BePharma
Not Confirmed

Omnivium Pharmaceuticals

Dosage Form : TABLET;ORAL

Brand Name : MONOKET

Dosage Strength : 20MG

Packaging :

Approval Date : 1993-06-30

Application Number : 20215

Regulatory Info : RX

Registration Country : USA

blank

07

Brand Name : MONOKET

BePharma
Not Confirmed
arrow

Brand Name : MONOKET

arrow
BePharma
Not Confirmed

Omnivium Pharmaceuticals

Dosage Form : TABLET;ORAL

Brand Name : MONOKET

Dosage Strength : 10MG

Packaging :

Approval Date : 1993-06-30

Application Number : 20215

Regulatory Info : RX

Registration Country : USA

blank

08

Brand Name : OLANZAPINE

BePharma
Not Confirmed
arrow

Brand Name : OLANZAPINE

arrow
BePharma
Not Confirmed

Omnivium Pharmaceuticals

Dosage Form : POWDER;INTRAMUSCULAR

Brand Name : OLANZAPINE

Dosage Strength : 10MG/VIAL

Packaging :

Approval Date : 2026-01-23

Application Number : 219048

Regulatory Info : RX

Registration Country : USA

blank

09

Brand Name : SODIUM BICARBONATE

BePharma
Not Confirmed
arrow

Brand Name : SODIUM BICARBONATE

arrow
BePharma
Not Confirmed

Omnivium Pharmaceuticals

Dosage Form : SOLUTION;INTRAVENOUS

Brand Name : SODIUM BICARBONATE

Dosage Strength : 50MEQ/50ML (1MEQ/ML)

Packaging :

Approval Date : 2023-06-15

Application Number : 216364

Regulatory Info : RX

Registration Country : USA

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

Brand Name : CLEMASTINE FUMARATE

BePharma
Not Confirmed
arrow

Brand Name : CLEMASTINE FUMARATE

BePharma
Not Confirmed
arrow

Omnivium Pharmaceuticals

Dosage Form : TABLET; ORAL

Proprietary Name : CLEMASTINE FUMARATE

Dosage Strength : 2.68MG

Approval Date : 1993-10-31

Application Number : 73459

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

02

Brand Name : NUMBRINO

BePharma
Not Confirmed
arrow

Brand Name : NUMBRINO

BePharma
Not Confirmed
arrow

Omnivium Pharmaceuticals

Dosage Form : SOLUTION; NASAL

Proprietary Name : NUMBRINO

Dosage Strength : 4%

Approval Date : 2020-01-10

Application Number : 209575

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

03

Brand Name : GLYCOPYRROLATE

BePharma
Not Confirmed
arrow

Brand Name : GLYCOPYRROLATE

BePharma
Not Confirmed
arrow

Omnivium Pharmaceuticals

Dosage Form : INJECTABLE; INJECTION

Proprietary Name : GLYCOPYRROLATE

Dosage Strength : 0.2MG/ML

Approval Date : 2022-11-29

Application Number : 212871

RX/OTC/DISCN : RX

RLD : No

TE Code : AP

blank

04

Brand Name : ISONIAZID

BePharma
Not Confirmed
arrow

Brand Name : ISONIAZID

BePharma
Not Confirmed
arrow

Omnivium Pharmaceuticals

Dosage Form : TABLET; ORAL

Proprietary Name : ISONIAZID

Dosage Strength : 100MG

Approval Date : 1997-06-26

Application Number : 40090

RX/OTC/DISCN : RX

RLD : No

TE Code : AA

blank

05

Brand Name : ISONIAZID

BePharma
Not Confirmed
arrow

Brand Name : ISONIAZID

BePharma
Not Confirmed
arrow

Omnivium Pharmaceuticals

Dosage Form : TABLET; ORAL

Proprietary Name : ISONIAZID

Dosage Strength : 300MG

Approval Date : 1997-06-26

Application Number : 40090

RX/OTC/DISCN : RX

RLD : No

TE Code : AA

blank

06

Brand Name : MONOKET

BePharma
Not Confirmed
arrow

Brand Name : MONOKET

BePharma
Not Confirmed
arrow

Omnivium Pharmaceuticals

Dosage Form : TABLET; ORAL

Proprietary Name : MONOKET

Dosage Strength : 20MG

Approval Date : 1993-06-30

Application Number : 20215

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank

07

Brand Name : MONOKET

BePharma
Not Confirmed
arrow

Brand Name : MONOKET

BePharma
Not Confirmed
arrow

Omnivium Pharmaceuticals

Dosage Form : TABLET; ORAL

Proprietary Name : MONOKET

Dosage Strength : 10MG

Approval Date : 1993-06-30

Application Number : 20215

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank

08

Brand Name : OLANZAPINE

BePharma
Not Confirmed
arrow

Brand Name : OLANZAPINE

BePharma
Not Confirmed
arrow

Omnivium Pharmaceuticals

Dosage Form : POWDER; INTRAMUSCULAR

Proprietary Name : OLANZAPINE

Dosage Strength : 10MG/VIAL

Approval Date : 2026-01-23

Application Number : 219048

RX/OTC/DISCN : RX

RLD : No

TE Code : AP

blank

09

Brand Name : SODIUM BICARBONATE

BePharma
Not Confirmed
arrow

Brand Name : SODIUM BICARBONATE

BePharma
Not Confirmed
arrow

Omnivium Pharmaceuticals

Dosage Form : SOLUTION; INTRAVENOUS

Proprietary Name : SODIUM BICARBONATE

Dosage Strength : 50MEQ/50ML (1MEQ/ML)

Approval Date : 2023-06-15

Application Number : 216364

RX/OTC/DISCN : RX

RLD : No

TE Code : AP

blank

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty